Sub-Total: $0.00
Emerging Biological Therapies for Psoriasis: Promising Efficacy of Interleukin‐17 (IL‐17) and IL‐23 Pathway Inhibitors
Complimentary
Related products
-
New Paradigms for Treatment and Management of Retinal Vein Occlusion (RVO)
Read more -
New Paradigms in the Treatment and Management of Neovascular Age-related Macular Degeneration (nAMD)
Read more -
Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options
Read more -
New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Read more
